GlaxoSmithKline (NYSE:GSK) dermatology and skin subsidiary Stiefel has submitted to regulators a new drug application for tazarotene foam, an acne skin care treatment product. If approved by the U.S.

GlaxoSmithKline‘s (NYSE:GSK) third quarter performance saw something that the pharma industry has had little occasion to cheer lately — sales growth. GSK did experience the expected sales declines of ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has announced the purchase of 167,000 of its own ordinary shares as part of its ...

GSK trades at lower price multiples compared to competitors due to weaker pipeline. GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix. GSK needs to demonstrate ...

LONDON/MUMBAI (Reuters) - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being ...

Cantor Fitzgerald has initiated coverage on Innoviva, Inc. (NASDAQ:INVA), citing the company’s unique business model centered around royalties and healthcare assets. The company receives royalties ...

GSK Pharma's current valuation already reflects the potential upside, hence Motilal Oswal reiterates Neutral stance on the ...

There's a nationwide shortage of Excedrin, a popular pain relief medication. The drugmaker, GlaxoSmithKline, has temporarily halted production to work out issues with the transfer and weighing of ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK plc has announced provisional dividend dates for the year 2026, outlining key ...

GlaxoSmithKline has become the first major pharmaceutical company to quit the industry’s decades-long practice of paying doctors to promote drugs to other doctors. Making the announcement on Monday, ...

LONDON/MUMBAI (Reuters) - Generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by ...

There's a nationwide shortage of Excedrin, a popular pain relief medication. The drugmaker, GlaxoSmithKline, has temporarily halted production to work out issues with the transfer and weighing of ...